Reshma Kewalramani, CEO and President of Vertex Pharmaceuticals Inc. (VRTX), has sold 15,580 shares of the company's stock. The transactions, which occurred on February 27, 2026, were executed at an average price of $495.38 per share, resulting in a total value of approximately $7.72 million.
This series of sales by Kewalramani involved multiple transactions throughout the day. Over the course of February 27, 2026, additional sales by Kewalramani included 240 shares for $115,881, 2,520 shares for $1,243,090, 3,278 shares for $1,600,549, 2,510 shares for $1,222,696, and 120 shares for $57,780.
Insider sales can be driven by various factors, including portfolio diversification, tax obligations, or pre-arranged trading plans, and do not necessarily reflect a negative outlook on the company's future performance.